Aura Biosciences, Inc.AURANASDAQ
Loading
EV/EBITDA Over TimeStrong
Percentile Rank60
Studio
Year-over-Year Change

Enterprise value to EBITDA ratio

Latest
-4.16
↑ 99% vs avg
Percentile
P60
Within normal range
Streak
2 yr
Consecutive declineStrong
Average
-310.94
Historical baseline
PeriodValueYoY Change
2024-4.16-5.8%
2023-3.94-9.0%
2022-3.61+64.3%
2021-10.11+47.9%
2020-19.42+98.9%
2019-1824.39-